Indication

Cal-1 Modified Hematopoietic Cellular Products

1 clinical trial

1 product

Clinical trial

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct

Status: Active (not recruiting), Estimated PCD: 2031-10-01

Product